The goal was to capture distinct features of the immune microenvironment associated with the presence or absence of P/LP germline variants in BC risk genes (BRCA1, BRCA2, BARD1, CHEK2, MUTYH, PALB2, and PMS2). This evidence concerns the gene CHEK2 and breast cancer.